natalizumab

natalizumab2016-12-25T08:23:17+00:00

natalizumab

IMMUNOLOGY, NEUROLOGY

Proprietary names Antegren, Tysabri

A humanised monoclonal antibody against alpha4 integrin, which has been used to treat multiple sclerosis and Crohn’s disease.

Adverse effects Fatigue, allergic reactions, headache, nausea, colds and exacerbation of Crohn’s disease in some patients, rarely it may cause demyelination (progressive multifocal leukoencephalopathy–PML), clinically significant liver damage in 0.1% of patients. 

Mechanism, PML Natalizumab inhibits alpha 4 integrin and suppresses the immune system so much it allows activation of  latent JC virus. 

References JAMA Neurology 2013; 70:469-475
http://en.wikipedia.org/wiki/Natalizumab

Leave A Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.